Direct and beta adrenergic blocking actions of nadolol (SQ 11725) on electrophysiologic properties of isolated canine myocardium

J. K. Gibson, H. Gelband, A. L. Bassett

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Effects of nadolol, a new beta adrenergic antagonist, were determined on transmembrane potentials of canine Purkinje fibers and ventricular and atrial muscle. Significant alterations in Purkinje fiber potentials occurred only with nadolol concentrations of 10-4 M or greater. After 1 hour exposure to 10-4 M, resting potential and action potential amplitude were reduced; at 3 hours, action potential rate of rise, phase 2 duration and action potential duration at 75% repolarization also were decreased. 10-3 M nadolol also was depressant and, additionally, consistently reduced membrane responsiveness. Nadolol (10-8-10-4 M) had no significant effects on effective refractory period. Ventricular and atrial muscle were less sensitive to all drug concentrations. Nadolol (10-8-10-4 M) had little action on automaticity in normal, ouabain-treated or stretched Purkinje fibers but markedly decreased catecholamine-enhanced automaticity. In isoproterenol-treated Purkinje fibers, pA2 for nadolol was 8.2 and 7.7 for propranolol. Nadolol (10-3 M or less) did not affect isometric force developed by isolated canine atrial trabeculae. The authors suggest that direct membrane depressant effects of nadolol do not contribute to its antiarrhythmic activity and that its beta adrenergic blocking ability is beneficial in catecholamine-related cardiac ectopia.

Original languageEnglish
Pages (from-to)702-710
Number of pages9
JournalJournal of Pharmacology and Experimental Therapeutics
Volume202
Issue number3
StatePublished - Dec 1 1977
Externally publishedYes

Fingerprint

Nadolol
Adrenergic Agents
Canidae
Myocardium
Purkinje Fibers
Action Potentials
Membrane Potentials
Catecholamines
Muscles
Adrenergic beta-Antagonists
Membranes
Ouabain
Isoproterenol
Propranolol

ASJC Scopus subject areas

  • Pharmacology

Cite this

Direct and beta adrenergic blocking actions of nadolol (SQ 11725) on electrophysiologic properties of isolated canine myocardium. / Gibson, J. K.; Gelband, H.; Bassett, A. L.

In: Journal of Pharmacology and Experimental Therapeutics, Vol. 202, No. 3, 01.12.1977, p. 702-710.

Research output: Contribution to journalArticle

@article{5a6931d3d466467490f66190c4f9f559,
title = "Direct and beta adrenergic blocking actions of nadolol (SQ 11725) on electrophysiologic properties of isolated canine myocardium",
abstract = "Effects of nadolol, a new beta adrenergic antagonist, were determined on transmembrane potentials of canine Purkinje fibers and ventricular and atrial muscle. Significant alterations in Purkinje fiber potentials occurred only with nadolol concentrations of 10-4 M or greater. After 1 hour exposure to 10-4 M, resting potential and action potential amplitude were reduced; at 3 hours, action potential rate of rise, phase 2 duration and action potential duration at 75{\%} repolarization also were decreased. 10-3 M nadolol also was depressant and, additionally, consistently reduced membrane responsiveness. Nadolol (10-8-10-4 M) had no significant effects on effective refractory period. Ventricular and atrial muscle were less sensitive to all drug concentrations. Nadolol (10-8-10-4 M) had little action on automaticity in normal, ouabain-treated or stretched Purkinje fibers but markedly decreased catecholamine-enhanced automaticity. In isoproterenol-treated Purkinje fibers, pA2 for nadolol was 8.2 and 7.7 for propranolol. Nadolol (10-3 M or less) did not affect isometric force developed by isolated canine atrial trabeculae. The authors suggest that direct membrane depressant effects of nadolol do not contribute to its antiarrhythmic activity and that its beta adrenergic blocking ability is beneficial in catecholamine-related cardiac ectopia.",
author = "Gibson, {J. K.} and H. Gelband and Bassett, {A. L.}",
year = "1977",
month = "12",
day = "1",
language = "English",
volume = "202",
pages = "702--710",
journal = "Journal of Pharmacology and Experimental Therapeutics",
issn = "0022-3565",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "3",

}

TY - JOUR

T1 - Direct and beta adrenergic blocking actions of nadolol (SQ 11725) on electrophysiologic properties of isolated canine myocardium

AU - Gibson, J. K.

AU - Gelband, H.

AU - Bassett, A. L.

PY - 1977/12/1

Y1 - 1977/12/1

N2 - Effects of nadolol, a new beta adrenergic antagonist, were determined on transmembrane potentials of canine Purkinje fibers and ventricular and atrial muscle. Significant alterations in Purkinje fiber potentials occurred only with nadolol concentrations of 10-4 M or greater. After 1 hour exposure to 10-4 M, resting potential and action potential amplitude were reduced; at 3 hours, action potential rate of rise, phase 2 duration and action potential duration at 75% repolarization also were decreased. 10-3 M nadolol also was depressant and, additionally, consistently reduced membrane responsiveness. Nadolol (10-8-10-4 M) had no significant effects on effective refractory period. Ventricular and atrial muscle were less sensitive to all drug concentrations. Nadolol (10-8-10-4 M) had little action on automaticity in normal, ouabain-treated or stretched Purkinje fibers but markedly decreased catecholamine-enhanced automaticity. In isoproterenol-treated Purkinje fibers, pA2 for nadolol was 8.2 and 7.7 for propranolol. Nadolol (10-3 M or less) did not affect isometric force developed by isolated canine atrial trabeculae. The authors suggest that direct membrane depressant effects of nadolol do not contribute to its antiarrhythmic activity and that its beta adrenergic blocking ability is beneficial in catecholamine-related cardiac ectopia.

AB - Effects of nadolol, a new beta adrenergic antagonist, were determined on transmembrane potentials of canine Purkinje fibers and ventricular and atrial muscle. Significant alterations in Purkinje fiber potentials occurred only with nadolol concentrations of 10-4 M or greater. After 1 hour exposure to 10-4 M, resting potential and action potential amplitude were reduced; at 3 hours, action potential rate of rise, phase 2 duration and action potential duration at 75% repolarization also were decreased. 10-3 M nadolol also was depressant and, additionally, consistently reduced membrane responsiveness. Nadolol (10-8-10-4 M) had no significant effects on effective refractory period. Ventricular and atrial muscle were less sensitive to all drug concentrations. Nadolol (10-8-10-4 M) had little action on automaticity in normal, ouabain-treated or stretched Purkinje fibers but markedly decreased catecholamine-enhanced automaticity. In isoproterenol-treated Purkinje fibers, pA2 for nadolol was 8.2 and 7.7 for propranolol. Nadolol (10-3 M or less) did not affect isometric force developed by isolated canine atrial trabeculae. The authors suggest that direct membrane depressant effects of nadolol do not contribute to its antiarrhythmic activity and that its beta adrenergic blocking ability is beneficial in catecholamine-related cardiac ectopia.

UR - http://www.scopus.com/inward/record.url?scp=0017691747&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017691747&partnerID=8YFLogxK

M3 - Article

C2 - 19621

AN - SCOPUS:0017691747

VL - 202

SP - 702

EP - 710

JO - Journal of Pharmacology and Experimental Therapeutics

JF - Journal of Pharmacology and Experimental Therapeutics

SN - 0022-3565

IS - 3

ER -